Subcellular Distribution of Envoplakin and Periplakin

Total Page:16

File Type:pdf, Size:1020Kb

Subcellular Distribution of Envoplakin and Periplakin Subcellular Distribution of Envoplakin and Periplakin: Insights into Their Role as Precursors of the Epidermal Cornified Envelope Teresa DiColandrea, Tadashi Karashima, Arto Määttä, and Fiona M. Watt Keratinocyte Laboratory, Imperial Cancer Research Fund, London WC2A 3PX, England Abstract. Envoplakin and periplakin are two plakins moplakin, that of periplakin localized to desmosomes; that are precursors of the epidermal cornified envelope. however, in addition, the periplakin NH2 terminus ac- We studied their distribution and interactions by trans- cumulated at cell surface microvilli in association with fection of primary human keratinocytes and other cells. cortical actin. Endogenous periplakin was redistributed Full-length periplakin localized to desmosomes, the in- from microvilli when keratinocytes were treated with terdesmosomal plasma membrane and intermediate the actin disrupting drug Latrunculin B. We propose filaments. Full length envoplakin also localized to des- that whereas envoplakin and periplakin can localize in- mosomes, but mainly accumulated in nuclear and cyto- dependently to desmosomes, the distribution of en- plasmic aggregates with associated intermediate fila- voplakin at the interdesmosomal plasma membrane de- ments. The envoplakin rod domain was required for pends on heterodimerization with periplakin and that aggregation and the periplakin rod domain was neces- the NH2 terminus of periplakin therefore plays a key sary and sufficient to redistribute envoplakin to desmo- role in forming the scaffold on which the cornified en- somes and the cytoskeleton, confirming earlier predic- velope is assembled. tions that the proteins can heterodimerize. The linker domain of each protein was required for intermediate Key words: envoplakin • periplakin • desmosomes • filament association. Like the NH2 terminus of des- cornified envelope • keratinocytes Introduction One important function of mammalian epidermis is to sequencing of peptides released from envelopes during provide a physical barrier between the body and the envi- controlled sequential proteolysis (Marekov and Steinert, ronment. This function depends on a structure known as 1998; Steinert and Marekov, 1995, 1997, 1999). An early the cornified envelope that is formed in the outermost epi- step in envelope assembly is transglutaminase-mediated dermal layers (Reichert et al., 1993; Simon, 1994; Ishida- oligomerization of a precursor known as involucrin. Since Yamamoto and Iizuka, 1998; Nemes and Steinert, 1999). involucrin is a cytosolic protein there must be a mecha- The cornified envelope is assembled from a range of pre- nism by which it becomes associated with the plasma cursor proteins that become cross-linked to one another membrane. It is believed that this occurs by cross-linking through the activity of transglutaminases. The resulting of involucrin to two proteins, envoplakin and periplakin, structure is an insoluble layer of protein with covalently which are found at desmosomes and the interdesmosomal ,nm thick, that is deposited on the in- plasma membrane (Simon and Green, 1984; Ma and Sun-15ف ,attached lipid ner surface of the plasma membrane. 1986; Ruhrberg et al., 1996, 1997). Subsequent to incorpo- The most current model of how the cornified envelope ration of involucrin, envoplakin, and periplakin into the is assembled (Steinert and Marekov, 1999) is based on two envelope, further proteins are added, including small pro- types of data: immunoelectron microscopy of isolated en- line-rich proteins, loricrin, and keratin filaments. velopes using antibodies to known precursor proteins, and Envoplakin and periplakin belong to the plakin family of cytolinker proteins that also includes desmoplakin, T. DiColandrea and T. Karashima are joint first authors. plectin, and BPAG1 (reviewed by Ruhrberg and Watt, Address correspondence to Fiona M. Watt, Imperial Cancer Research 1997; Fuchs and Cleveland, 1998; Houseweart and Cleve- Fund, P.O. Box 123, 44 Lincoln’s Inn Fields, London WC2A 3PX, En- land, 1998; Fuchs and Yang, 1999; Herrmann and Aebi, gland. Tel.: 44 20 7269 3528; Fax: 44 20 7269 3078; E-mail: watt@icrf. icnet.uk 2000). In addition to being expressed in the epidermis, en- T. Karashima is on leave from Department of Dermatology, Kurume Uni- voplakin and periplakin are found in other stratified epi- versity School of Medicine, 67 Asahimachi, Kurume, Fukuoka 830, Japan. thelia and in two-layered and transitional epithelia such as The Rockefeller University Press, 0021-9525/2000/10/573/13 $5.00 The Journal of Cell Biology, Volume 151, Number 3, October 30, 2000 573–585 http://www.jcb.org/cgi/content/full/151/3/573 573 the mammary gland and bladder (Ruhrberg et al., 1996, teins and their individual domains by stable and transient 1997; Aho et al., 1998). Periplakin is also highly expressed transfection of primary human keratinocytes and other cell in brain (Aho et al., 1998). In differentiating keratinocytes types. We demonstrate a key role for periplakin in direct- that have not yet assembled a cornified envelope en- ing the subcellular distribution of both proteins and, specif- voplakin and periplakin are found at desmosomal plaques, ically, for the NH2 terminus of periplakin in targeting the in close proximity to desmoplakin, in an interdesmosomal proteins to the interdesmosomal plasma membrane. network at the plasma membrane, and associated with keratin filaments (Ruhrberg et al., 1996, 1997). Materials and Methods All conventional plakins comprise an NH2-terminal glob- ular domain, a central rod domain and a COOH-terminal Generation of cDNA Constructs globular domain. More distantly related proteins include Drosophila kakapo (Stumpf and Volk, 1998; Gregory and Plasmids containing partial cDNAs (Ruhrberg et al., 1996, 1997) for both Brown, 1998) and its mammalian homolgue ACF7 (Leung envoplakin and periplakin were used to create full-length cDNAs by using unique restriction enzyme digests to allow fusion of multiple cDNA frag- et al., 1999; Karakesisoglou et al., 2000), which share ho- ments and assembly into pBluescript II KSϩ/Ϫ (Stratagene). The full- mology with plakins at the NH2 terminus and with dystro- length cDNAs were then tagged with either influenza virus hemagglutinin 1 phin at the COOH terminus. The NH2-terminal domain is (HA ; periplakin) or FLAG (envoplakin) protein coding sequences in a known to direct desmoplakin and plectin to membrane lo- PCR reaction using primers that linked the epitope tags in frame with the plakin cDNAs at the COOH-terminal ends. Subsequently, the new calization sites (desmosomes and hemidesmosomes, re- COOH-terminal fragments were ligated to the cDNA in pBluescript and spectively) (Bornslaeger et al., 1996; Smith and Fuchs, the resulting tagged cDNA was subcloned into pCI-neo, a mammalian ex- 1998; Wiche, 1998; Geerts et al., 1999). Plectin and some al- pression vector from Promega. The primers used were: AGGCCCTC- ternatively spliced variants of BPAG1 have, in addition, an CTCTCCGGGATGATCAGTGAAGA (envoplakin COOH terminus, NH -terminal actin binding domain (Yang et al., 1996; Liu 5Ј end); GCTCTAGAGCTCACTTGTCATCGTCGTCCTTGTAGT- 2 CGCGAAGGGAGCGCGGGACGGTGGGGGAGGCGGAGCGGTA et al., 1996; Andrä et al., 1998; Fuchs et al., 1999). One of (envoplakin COOH-terminal FLAG tag, 3Ј end); AAGGTAACCCAT- the BPAG1 isoforms has an NH2-terminal microtubule ACGCAGAAGGTGGTGCTGCA (periplakin COOH terminus, 5Ј binding site (Yang et al., 1999) and plectin interacts with end); CCAAGCTTGGGTCTAGAGCGGCCGCCTAAGCGTAGTCT- microtubules, probably via microtubule-associated proteins GGCACGTCGTATGGGTACTTCTGCCCAGATACCAAGACCGCA (periplakin COOH-terminal HA tag, 3Ј end). (Svitkina et al., 1996; Wiche, 1998). The central rod domain All truncated periplakin cDNAs were constructed by PCR amplifica- forms a coiled coil structure that mediates assembly of tion from the full-length cDNA linking the epitope tag to the mutant plakins into parallel homodimers (Green et al., 1990, 1992; cDNA in frame at either the NH2-terminal or COOH-terminal end (see Wiche et al., 1991; Sawamura et al., 1991) and the COOH- Fig. 1). Primers for generating the periplakin cDNA fused with the HA terminal globular domains of desmoplakin, plectin, and epitope tag were as follows: 5Ј-GACCGAGTCGACCTACGCATAG- TCAGGAACATCGTATGGGTAATTCTCGGTCTTCAGCACCTC- BPAG1 bind intermediate filaments (Foisner et al., 1988; ATACCGCTGCT (P-1/2N); 5Ј-AAGACGAATTCGCCGCCACCA- Stappenbeck and Green, 1992; Stappenbeck et al., 1993; TGTACCCATACGATGTTCCTGACTATGCGCAGAAGCGCCTG- Wiche et al., 1993; Kouklis et al., 1994; Nikolic et al., 1996; GGCTCC (P-C); 5Ј-GACCGAGTCGACCTACGCATAGTCAGGA- Yang et al., 1996; Steinböck et al., 2000). ACATCGTATGGGTAGACGGCCACGGAGCCCAGGCGCTT (P-R and P-NR); 5Ј- GTGCTCAAGAATTCAGCCACCATGTACCCA- Although periplakin and envoplakin share the overall TACGATGTTCCTGACTATGCGCAGGAATCGGTGGTGAGGAA- structure of desmoplakin, plectin, and BPAG1, their GGAGGTGCT (P-RC). COOH-terminal domains, are considerably smaller, with All the envoplakin partial cDNAs except for E-NR and E-RC (see Fig. envoplakin having only one of the globular subdomains 1) were assembled using PCR reactions to amplify targeted sequences (the C box) and periplakin none (Ruhrberg et al., 1996, which were then subcloned in frame into a modified pCI-neo vector (F9). F9 was created by inserting the FLAG epitope into the SmaI site of the 1997; Aho et al., 1998). The COOH termini of envoplakin pCI multicloning region, flanked by an ATG start site, a TAG termination and periplakin do, however, include the recently defined
Recommended publications
  • Table 2. Significant
    Table 2. Significant (Q < 0.05 and |d | > 0.5) transcripts from the meta-analysis Gene Chr Mb Gene Name Affy ProbeSet cDNA_IDs d HAP/LAP d HAP/LAP d d IS Average d Ztest P values Q-value Symbol ID (study #5) 1 2 STS B2m 2 122 beta-2 microglobulin 1452428_a_at AI848245 1.75334941 4 3.2 4 3.2316485 1.07398E-09 5.69E-08 Man2b1 8 84.4 mannosidase 2, alpha B1 1416340_a_at H4049B01 3.75722111 3.87309653 2.1 1.6 2.84852656 5.32443E-07 1.58E-05 1110032A03Rik 9 50.9 RIKEN cDNA 1110032A03 gene 1417211_a_at H4035E05 4 1.66015788 4 1.7 2.82772795 2.94266E-05 0.000527 NA 9 48.5 --- 1456111_at 3.43701477 1.85785922 4 2 2.8237185 9.97969E-08 3.48E-06 Scn4b 9 45.3 Sodium channel, type IV, beta 1434008_at AI844796 3.79536664 1.63774235 3.3 2.3 2.75319499 1.48057E-08 6.21E-07 polypeptide Gadd45gip1 8 84.1 RIKEN cDNA 2310040G17 gene 1417619_at 4 3.38875643 1.4 2 2.69163229 8.84279E-06 0.0001904 BC056474 15 12.1 Mus musculus cDNA clone 1424117_at H3030A06 3.95752801 2.42838452 1.9 2.2 2.62132809 1.3344E-08 5.66E-07 MGC:67360 IMAGE:6823629, complete cds NA 4 153 guanine nucleotide binding protein, 1454696_at -3.46081884 -4 -1.3 -1.6 -2.6026947 8.58458E-05 0.0012617 beta 1 Gnb1 4 153 guanine nucleotide binding protein, 1417432_a_at H3094D02 -3.13334396 -4 -1.6 -1.7 -2.5946297 1.04542E-05 0.0002202 beta 1 Gadd45gip1 8 84.1 RAD23a homolog (S.
    [Show full text]
  • Cytoskeletal Linkers: New Maps for Old Destinations Megan K
    R864 Dispatch Cytoskeletal linkers: New MAPs for old destinations Megan K. Houseweart*† and Don W. Cleveland*†‡§ A new isoform of the actin–neurofilament linker protein as ‘bullous pemphigoid antigen’ (BPAG). These proteins BPAG has been found that binds to and stabilizes are large α-helical coiled-coil molecules which have axonal microtubules. This and other newly identified binding domains for one or more of the three cytoskele- microtubule-associated proteins are likely to be just the tal components (Figure 1). For example, the widely tip of an iceberg of multifunctional proteins that expressed, > 500 kD protein plectin has been shown to stabilize and crosslink cytoskeletal filament networks. associate with microtubules, intermediate filaments (glial fibrillary acidic protein, vimentin, keratins, all Addresses: *Ludwig Institute for Cancer Research, †Program in Biomedical Sciences, ‡Division of Cellular and Molecular Medicine and three neurofilament subunit proteins), actin, myosin and §Department of Neuroscience, University of California at San Diego, itself [3]. Given the widespread distribution and multi- La Jolla, California 92093, USA. ple interactions that are characteristic of these proteins, E-mail: [email protected] it is not surprising that a number of human and mouse Current Biology 1999, 9:R864–R866 diseases have been attributed to aberrant or missing cross-linking proteins [4]. 0960-9822/99/$ – see front matter © 1999 Elsevier Science Ltd. All rights reserved. This is the case for mice lacking the locus encoding the numerous isoforms of the essential ~280 kDa linker The cytoplasm of most eukaryotic cells contains a dynamic protein BPAG. Two neuronal isoforms of BPAG both have filamentous protein scaffold composed of 25 nm micro- a carboxy-terminal intermediate-filament-binding domain tubules, 4 nm actin filaments and 10 nm intermediate fila- and also an amino-terminal actin-binding region (Figure 1).
    [Show full text]
  • Method of Prognosing Cancers Verfahren Zur Prognose Von Krebsarten Procédé De Prognostic Des Cancers
    (19) TZZ Z _T (11) EP 2 295 602 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: G01N 33/574 (2006.01) C12Q 1/68 (2006.01) 11.07.2012 Bulletin 2012/28 (21) Application number: 10178350.4 (22) Date of filing: 26.07.2006 (54) Method of prognosing cancers Verfahren zur Prognose von Krebsarten Procédé de prognostic des cancers (84) Designated Contracting States: • KIHARA C ET AL: "Prediction of sensitivity of AT BE BG CH CY CZ DE DK EE ES FI FR GB GR esophageal tumors to adjuvant chemotherapy by HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI cDNA microarray analysis of gene-expression SK TR profiles", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, (30) Priority: 27.07.2005 US 703263 P BALTIMORE, MD, US, vol. 61, no. 17, September 2001 (2001-09), pages 6474-6479, XP002960719, (43) Date of publication of application: ISSN: 0008-5472 16.03.2011 Bulletin 2011/11 • PORTE H ET AL: "Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in (62) Document number(s) of the earlier application(s) in human esophageal carcinoma: implications for accordance with Art. 76 EPC: prognosis.", CLINICAL CANCER RESEARCH : 06782211.4 / 1 907 582 AN OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH. JUN (73) Proprietor: Oncotherapy Science, Inc. 1998, vol. 4, no. 6, June 1998 (1998-06), pages Kawasaki-shi 1375-1382, XP002407525, ISSN: 1078-0432 Kanagawa 213-0012 (JP) • "Affimetrix GeneChip Human Genome U133 Array Set HG-U133A", GEO, 11 March 2002 (72) Inventors: (2002-03-11), XP002254749, • Nakamura, Yusuke • WIGLE DENNIS A ET AL: "Molecular profiling of Tokyo 1138654 (JP) non-small cell lung cancer and correlation with • Daigo, Yataro disease-free survival", CANCER RESEARCH, Tokyo 1138654 (JP) AMERICAN ASSOCIATION FOR CANCER • Nakatsuru, Shuichi REREARCH, US, vol.
    [Show full text]
  • Microtubule-Actin Crosslinking Factor 1 and Plakins As Therapeutic Drug Targets
    Tennessee State University Digital Scholarship @ Tennessee State University Biology Faculty Research Department of Biological Sciences 1-26-2018 Microtubule-Actin Crosslinking Factor 1 and Plakins as Therapeutic Drug Targets Quincy A. Quick Tennessee State University Follow this and additional works at: https://digitalscholarship.tnstate.edu/biology_fac Part of the Pharmacology Commons Recommended Citation Quick, Q.A. Microtubule-Actin Crosslinking Factor 1 and Plakins as Therapeutic Drug Targets. Int. J. Mol. Sci. 2018, 19, 368. https://doi.org/10.3390/ijms19020368 This Article is brought to you for free and open access by the Department of Biological Sciences at Digital Scholarship @ Tennessee State University. It has been accepted for inclusion in Biology Faculty Research by an authorized administrator of Digital Scholarship @ Tennessee State University. For more information, please contact [email protected]. International Journal of Molecular Sciences Review Microtubule-Actin Crosslinking Factor 1 and Plakins as Therapeutic Drug Targets Quincy A. Quick Department of Biological Sciences, Tennessee State University, 3500 John A. Merritt Blvd, Nashville, TN 37209, USA; [email protected]; Tel.: +1-(615) 963-5768 Received: 11 December 2017; Accepted: 23 January 2018; Published: 26 January 2018 Abstract: Plakins are a family of seven cytoskeletal cross-linker proteins (microtubule-actin crosslinking factor 1 (MACF), bullous pemphigoid antigen (BPAG1) desmoplakin, envoplakin, periplakin, plectin, epiplakin) that network the three major filaments that comprise the cytoskeleton. Plakins have been found to be involved in disorders and diseases of the skin, heart, nervous system, and cancer that are attributed to autoimmune responses and genetic alterations of these macromolecules. Despite their role and involvement across a spectrum of several diseases, there are no current drugs or pharmacological agents that specifically target the members of this protein family.
    [Show full text]
  • Gene Expression Signatures and Biomarkers of Noninvasive And
    Oncogene (2006) 25, 2328–2338 & 2006 Nature Publishing Group All rights reserved 0950-9232/06 $30.00 www.nature.com/onc ORIGINAL ARTICLE Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: comprehensive profiles by representational difference analysis, microarrays and proteomics GM Nagaraja1, M Othman2, BP Fox1, R Alsaber1, CM Pellegrino3, Y Zeng2, R Khanna2, P Tamburini3, A Swaroop2 and RP Kandpal1 1Department of Biological Sciences, Fordham University, Bronx, NY, USA; 2Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USA and 3Bayer Corporation, West Haven, CT, USA We have characterized comprehensive transcript and Keywords: representational difference analysis; micro- proteomic profiles of cell lines corresponding to normal arrays; proteomics; breast carcinoma; biomarkers; breast (MCF10A), noninvasive breast cancer (MCF7) and copper homeostasis invasive breast cancer (MDA-MB-231). The transcript profiles were first analysed by a modified protocol for representational difference analysis (RDA) of cDNAs between MCF7 and MDA-MB-231 cells. The majority of genes identified by RDA showed nearly complete con- Introduction cordance withmicroarray results, and also led to the identification of some differentially expressed genes such The transformation of a normal cell into a cancer cell as lysyl oxidase, copper transporter ATP7A, EphB6, has been correlated to altered expression of a variety of RUNX2 and a variant of RUNX2. The altered transcripts genes (Perou et al., 2000; Becker et al., 2005). The identified by microarray analysis were involved in cell–cell expression of some of these genes is a direct result of or cell–matrix interaction, Rho signaling, calcium home- sequence mutation, whereas other changes occur due to ostasis and copper-binding/sensitive activities.
    [Show full text]
  • MALE Protein Name Accession Number Molecular Weight CP1 CP2 H1 H2 PDAC1 PDAC2 CP Mean H Mean PDAC Mean T-Test PDAC Vs. H T-Test
    MALE t-test t-test Accession Molecular H PDAC PDAC vs. PDAC vs. Protein Name Number Weight CP1 CP2 H1 H2 PDAC1 PDAC2 CP Mean Mean Mean H CP PDAC/H PDAC/CP - 22 kDa protein IPI00219910 22 kDa 7 5 4 8 1 0 6 6 1 0.1126 0.0456 0.1 0.1 - Cold agglutinin FS-1 L-chain (Fragment) IPI00827773 12 kDa 32 39 34 26 53 57 36 30 55 0.0309 0.0388 1.8 1.5 - HRV Fab 027-VL (Fragment) IPI00827643 12 kDa 4 6 0 0 0 0 5 0 0 - 0.0574 - 0.0 - REV25-2 (Fragment) IPI00816794 15 kDa 8 12 5 7 8 9 10 6 8 0.2225 0.3844 1.3 0.8 A1BG Alpha-1B-glycoprotein precursor IPI00022895 54 kDa 115 109 106 112 111 100 112 109 105 0.6497 0.4138 1.0 0.9 A2M Alpha-2-macroglobulin precursor IPI00478003 163 kDa 62 63 86 72 14 18 63 79 16 0.0120 0.0019 0.2 0.3 ABCB1 Multidrug resistance protein 1 IPI00027481 141 kDa 41 46 23 26 52 64 43 25 58 0.0355 0.1660 2.4 1.3 ABHD14B Isoform 1 of Abhydrolase domain-containing proteinIPI00063827 14B 22 kDa 19 15 19 17 15 9 17 18 12 0.2502 0.3306 0.7 0.7 ABP1 Isoform 1 of Amiloride-sensitive amine oxidase [copper-containing]IPI00020982 precursor85 kDa 1 5 8 8 0 0 3 8 0 0.0001 0.2445 0.0 0.0 ACAN aggrecan isoform 2 precursor IPI00027377 250 kDa 38 30 17 28 34 24 34 22 29 0.4877 0.5109 1.3 0.8 ACE Isoform Somatic-1 of Angiotensin-converting enzyme, somaticIPI00437751 isoform precursor150 kDa 48 34 67 56 28 38 41 61 33 0.0600 0.4301 0.5 0.8 ACE2 Isoform 1 of Angiotensin-converting enzyme 2 precursorIPI00465187 92 kDa 11 16 20 30 4 5 13 25 5 0.0557 0.0847 0.2 0.4 ACO1 Cytoplasmic aconitate hydratase IPI00008485 98 kDa 2 2 0 0 0 0 2 0 0 - 0.0081 - 0.0
    [Show full text]
  • Caspase 6 Disconnects Intermediate Filament-Binding Domain of Periplakin from Its Actin-Binding N-Terminal Region
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Breaking the Connection: Caspase 6 Disconnects Intermediate Filament-Binding Domain of Periplakin from its Actin-Binding N-Terminal Region Andrey E. Kalinin,Ã Alexandr E. Kalinin,Ã Mikko Aho,w Jouni Uitto,w and Sirpa Ahow ÃLaboratory of Skin Biology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA; wDepartment of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA Periplakin is a member of the plakin family of cytolinkers that connect cytoskeletal networks to each other as well as to the cell junctional complexes. Here, we demonstrate a direct molecular interaction between actin and pe- riplakin. Furthermore, the oligomerization state of periplakin was shown to determine specificity of its binding to intermediate filaments (IF) in vitro. Both the filament association and the cell membrane localization of periplakin were confirmed in the cells overexpressing human periplakin. Double labeling of the N- and C-terminally tagged periplakin revealed unexpected lack of co-localization of periplakin ends in a confluent culture, and separation of the periplakin ends was even more pronounced in apoptotic cells. Western analysis revealed that after induction of apoptosis, periplakin becomes cleaved close to its C-terminal tail. Only the distinct cleavage products, but not the full-length periplakin, were present in the cells detached from the solid support during the apoptotic process. We show that caspase 6 cleaves periplakin at an unconventional recognition site, amino acid sequence TVAD. Thus, the separation of periplakin ends disconnects the actin-binding head-rod domain from the IF-binding C-terminal domain.
    [Show full text]
  • Human Induced Pluripotent Stem Cell–Derived Podocytes Mature Into Vascularized Glomeruli Upon Experimental Transplantation
    BASIC RESEARCH www.jasn.org Human Induced Pluripotent Stem Cell–Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation † Sazia Sharmin,* Atsuhiro Taguchi,* Yusuke Kaku,* Yasuhiro Yoshimura,* Tomoko Ohmori,* ‡ † ‡ Tetsushi Sakuma, Masashi Mukoyama, Takashi Yamamoto, Hidetake Kurihara,§ and | Ryuichi Nishinakamura* *Department of Kidney Development, Institute of Molecular Embryology and Genetics, and †Department of Nephrology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; ‡Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, Japan; §Division of Anatomy, Juntendo University School of Medicine, Tokyo, Japan; and |Japan Science and Technology Agency, CREST, Kumamoto, Japan ABSTRACT Glomerular podocytes express proteins, such as nephrin, that constitute the slit diaphragm, thereby contributing to the filtration process in the kidney. Glomerular development has been analyzed mainly in mice, whereas analysis of human kidney development has been minimal because of limited access to embryonic kidneys. We previously reported the induction of three-dimensional primordial glomeruli from human induced pluripotent stem (iPS) cells. Here, using transcription activator–like effector nuclease-mediated homologous recombination, we generated human iPS cell lines that express green fluorescent protein (GFP) in the NPHS1 locus, which encodes nephrin, and we show that GFP expression facilitated accurate visualization of nephrin-positive podocyte formation in
    [Show full text]
  • “Deciphering the Genetic Architecture of Prolificacy Related Traits in an Experimental Iberian X Meishan F2 Intercross”
    UNIVERSITAT AUTÒNOMA DE BARCELONA Departament de Ciència Animal i dels Aliments Facultat de Veterinària “Deciphering the genetic architecture of prolificacy related traits in an experimental Iberian x Meishan F2 intercross” Ingrid Balcells Ortega PhD Thesis June, 2012 Supervisors: Armand Sánchez and Anna Tomás El Dr. Armand Sánchez Bonastre, catedràtic del Departament de Ciència Animal i dels Aliments de la Universitat Autònoma de Barcelona i la Dra. Anna Tomás Sangenís, investigadora en la Fundació d'Investigació Sanitària de les Illes Balears de Mallorca CERTIFIQUEN: Que l’Ingrid Balcells Ortega ha realitzat sota la seva direcció el treball de recerca “Deciphering the genetic architecture of prolificacy related traits in an experimental Iberian x Meishan F2 intercross” per a obtenir el grau de doctora per la Universitat Autònoma de Barcelona. Que aquest treball s’ha dut a terme al Departament de Ciència Animal i dels Aliments de la Facultat de Veterinària de la Universitat Autònoma de Barcelona. Bellaterra, 11 de Maig de 2012 Dr. Armand Sánchez Bonastre Dra. Anna Tomás Sangenís ACKNOWLEDGEMENTS Durant la realització d’aquesta tesi, han sigut moltes les persones que m’han acompanyat, tan a nivell professional com personal. Totes elles han aportat el seu granet de sorra per a que aquest projecte hagi tirat endavant i han fet que pugui recordar aquesta etapa amb un gran somriure a la cara. Als meus directors de tesi, el doctor Armand Sánchez i la doctora Anna Tomás. Per tota la confiança que heu dipositat en mi, per tots els coneixements que m’heu transmès, per donar-me copets a l’esquena en els moments de més desànim (sobretot en aquests últims mesos) i per mil coses més.
    [Show full text]
  • Fibroblasts from the Human Skin Dermo-Hypodermal Junction Are
    cells Article Fibroblasts from the Human Skin Dermo-Hypodermal Junction are Distinct from Dermal Papillary and Reticular Fibroblasts and from Mesenchymal Stem Cells and Exhibit a Specific Molecular Profile Related to Extracellular Matrix Organization and Modeling Valérie Haydont 1,*, Véronique Neiveyans 1, Philippe Perez 1, Élodie Busson 2, 2 1, 3,4,5,6, , Jean-Jacques Lataillade , Daniel Asselineau y and Nicolas O. Fortunel y * 1 Advanced Research, L’Oréal Research and Innovation, 93600 Aulnay-sous-Bois, France; [email protected] (V.N.); [email protected] (P.P.); [email protected] (D.A.) 2 Department of Medical and Surgical Assistance to the Armed Forces, French Forces Biomedical Research Institute (IRBA), 91223 CEDEX Brétigny sur Orge, France; [email protected] (É.B.); [email protected] (J.-J.L.) 3 Laboratoire de Génomique et Radiobiologie de la Kératinopoïèse, Institut de Biologie François Jacob, CEA/DRF/IRCM, 91000 Evry, France 4 INSERM U967, 92260 Fontenay-aux-Roses, France 5 Université Paris-Diderot, 75013 Paris 7, France 6 Université Paris-Saclay, 78140 Paris 11, France * Correspondence: [email protected] (V.H.); [email protected] (N.O.F.); Tel.: +33-1-48-68-96-00 (V.H.); +33-1-60-87-34-92 or +33-1-60-87-34-98 (N.O.F.) These authors contributed equally to the work. y Received: 15 December 2019; Accepted: 24 January 2020; Published: 5 February 2020 Abstract: Human skin dermis contains fibroblast subpopulations in which characterization is crucial due to their roles in extracellular matrix (ECM) biology.
    [Show full text]
  • Adaptor Periplakin Phosphoantigens and the Cytoskeletal Interactions Of
    Activation of Human δγ T Cells by Cytosolic Interactions of BTN3A1 with Soluble Phosphoantigens and the Cytoskeletal Adaptor Periplakin This information is current as of October 1, 2021. David A. Rhodes, Hung-Chang Chen, Amanda J. Price, Anthony H. Keeble, Martin S. Davey, Leo C. James, Matthias Eberl and John Trowsdale J Immunol published online 30 January 2015 http://www.jimmunol.org/content/early/2015/01/30/jimmun Downloaded from ol.1401064 Supplementary http://www.jimmunol.org/content/suppl/2015/01/30/jimmunol.140106 Material 4.DCSupplemental http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on October 1, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2015 The Authors All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published January 30, 2015, doi:10.4049/jimmunol.1401064 The Journal of Immunology Activation of Human gd T Cells by Cytosolic Interactions of BTN3A1 with Soluble Phosphoantigens and the Cytoskeletal Adaptor Periplakin David A. Rhodes,* Hung-Chang Chen,†,1 Amanda J. Price,‡,1 Anthony H.
    [Show full text]
  • Cytoskeletal Proteins in Neurological Disorders
    cells Review Much More Than a Scaffold: Cytoskeletal Proteins in Neurological Disorders Diana C. Muñoz-Lasso 1 , Carlos Romá-Mateo 2,3,4, Federico V. Pallardó 2,3,4 and Pilar Gonzalez-Cabo 2,3,4,* 1 Department of Oncogenomics, Academic Medical Center, 1105 AZ Amsterdam, The Netherlands; [email protected] 2 Department of Physiology, Faculty of Medicine and Dentistry. University of Valencia-INCLIVA, 46010 Valencia, Spain; [email protected] (C.R.-M.); [email protected] (F.V.P.) 3 CIBER de Enfermedades Raras (CIBERER), 46010 Valencia, Spain 4 Associated Unit for Rare Diseases INCLIVA-CIPF, 46010 Valencia, Spain * Correspondence: [email protected]; Tel.: +34-963-395-036 Received: 10 December 2019; Accepted: 29 January 2020; Published: 4 February 2020 Abstract: Recent observations related to the structure of the cytoskeleton in neurons and novel cytoskeletal abnormalities involved in the pathophysiology of some neurological diseases are changing our view on the function of the cytoskeletal proteins in the nervous system. These efforts allow a better understanding of the molecular mechanisms underlying neurological diseases and allow us to see beyond our current knowledge for the development of new treatments. The neuronal cytoskeleton can be described as an organelle formed by the three-dimensional lattice of the three main families of filaments: actin filaments, microtubules, and neurofilaments. This organelle organizes well-defined structures within neurons (cell bodies and axons), which allow their proper development and function through life. Here, we will provide an overview of both the basic and novel concepts related to those cytoskeletal proteins, which are emerging as potential targets in the study of the pathophysiological mechanisms underlying neurological disorders.
    [Show full text]